Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-02 | Future report Set alerts | |
Q2 2022 | 2022-08-08 | -0.51 | -0.51 |
Q1 2022 | 2022-05-09 | -0.97 | -0.97 |
Q4 2021 | 2022-02-28 | -0.05 | -0.05 |
Q3 2021 | 2021-11-04 | -0.19 | -0.19 |
Q2 2021 | 2021-08-03 | -0.06 | -0.06 |
Q1 2021 | 2021-05-06 | 0.19 | 0.19 |
Q4 2020 | 2021-02-23 | 0.25 | 0.25 |
Q2 2020 | 2020-08-04 | -0.72 | -0.72 |
Q1 2020 | 2020-05-07 | -0.70 | -0.70 |
2016-07-01 | Initiated Coverage | Sidoti | Buy | $49.00 |
2016-05-09 | Reiterated Rating | B. Riley | Buy | $42.50 |
2016-05-04 | Reiterated Rating | B. Riley | Buy | $42.50 |
2016-04-28 | Reiterated Rating | B. Riley | Buy | $41.50 |
2016-04-01 | Initiated Coverage | CL King | Buy | |
2016-03-11 | Reiterated Rating | B. Riley | Buy | $41.50 |
2016-03-06 | Reiterated Rating | B. Riley | Neutral | $33.25 |
2016-03-04 | Upgrade | B. Riley | Neutral to Buy | $41.50 |
2016-03-01 | Reiterated Rating | B. Riley | Neutral | $33.25 |
2015-11-17 | Reiterated Rating | B. Riley | Neutral | $33.25 |
2015-11-12 | Reiterated Rating | B. Riley | Hold | $33.25 |
2015-11-09 | Boost Price Target | B. Riley | Neutral | $33.25 |
2015-07-29 | Reiterated Rating | B. Riley | Neutral | $31.00 |
2015-03-06 | Reiterated Rating | B. Riley | Neutral | $22.00 |
2015-02-04 | Downgrade | Sidoti | Buy to Neutral | |
2014-12-12 | Initiated | Gabelli & Co | Buy | $20 |
2014-12-12 | Initiated Coverage | Gabelli | Buy | $20.00 |
2014-05-09 | Reiterated Rating | Raymond James | Outperform | $12.50 to $13.00 |
2014-03-28 | Boost Price Target | B. Riley | $6.00 to $12.25 | |
2014-03-28 | Upgrade | Feltl & Co. | Buy to Strong-Buy | |
2014-01-30 | Downgrade | Feltl & Co. | Strong-Buy to Buy | |
2012-08-13 | Downgrade | C.K. Cooper | Buy to Hold | |
2012-06-08 | Initiated | C.K. Cooper | Buy | $20 |
2016-07-01 | Initiated Coverage | Sidoti | Buy | $49.00 |
2016-05-09 | Reiterated Rating | B. Riley | Buy | $42.50 |
2016-05-04 | Reiterated Rating | B. Riley | Buy | $42.50 |
2016-04-28 | Reiterated Rating | B. Riley | Buy | $41.50 |
2016-04-01 | Initiated Coverage | CL King | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HSKA 142 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 1.80M |
Nine Ten Capital Management LLC | 0.87M |
Vanguard Group, Inc | 0.71M |
FRED ALGER MANAGEMENT INC | 0.59M |
AMERIPRISE FINANCIAL INC | 0.52M |
FMR LLC | 0.45M |
STATE STREET CORP | 0.39M |
RIVERBRIDGE PARTNERS LLC | 0.32M |
Invesco Ltd. | 0.27M |
Grandeur Peak Global Advisors, LLC | 0.25M |
DIMENSIONAL FUND ADVISORS LP | 0.25M |
TimesSquare Capital Management, LLC | 0.24M |
BANK OF AMERICA CORP /DE/ | 0.20M |
BlackRock Institutional Trust Company, N.A. | 0.19M |
BlackRock Fund Advisors | 0.19M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
CMC Master Fund, L.P. | 8.42% (529664) | HSKA / |
GRIEVE ROBERT B Chief Executive Officer | 1.62% (101690) | HSKA / |
McGinley Michael J President and COO | 1.38% (86776) | HSKA / |
NAPOLITANO JASON A Exec. VP, CFO & Secretary | 0.69% (43119) | HSKA / |
Wisnewski Nancy EVP, Prod. Dev. & Cust. Supp | 0.64% (40358) | HSKA / |
AYLESWORTH WILLIAM A | 0.59% (37397) | HSKA / |
GORDON G IRWIN | 0.52% (32901) | HSKA / |
Eyl Steven M. EVP, Commercial Operations | 0.16% (10288) | HSKA / |
BENT MICHAEL A V.P.Actg. Officer & Controller | 0.16% (9773) | HSKA / |
SASEN JOHN F | 0.14% (8859) | HSKA / |
Lippincott Rod EVP, Comp. Animal Health Sales | 0.13% (8316) | HSKA / |
Asakowicz Steve EVP, Comp. Animal Health Sales | 0.13% (8276) | HSKA / |
Sveen David E. | 0.12% (7768) | HSKA / |
Wilson Kevin S. President and COO | 0.10% (6432) | HSKA / |
EIO PETER | 0.10% (6204) | HSKA / |
WRENN CAROL | 0.07% (4544) | HSKA / PAHC / |
Riley Sharon L. | 0.05% (3294) | HSKA / |
Humphrey Scott | 0.01% (567) | HSKA / |
Trowbridge Bonnie J. | 0.01% (544) | HSKA / |